Details for New Drug Application (NDA): 211362
✉ Email this page to a colleague
The generic ingredient in DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE is atropine sulfate; diphenoxylate hydrochloride. There are twenty-three drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the atropine sulfate; diphenoxylate hydrochloride profile page.
Summary for 211362
Tradename: | DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE |
Applicant: | Winder Labs Llc |
Ingredient: | atropine sulfate; diphenoxylate hydrochloride |
Patents: | 0 |
Pharmacology for NDA: 211362
Mechanism of Action | Cholinergic Antagonists Cholinergic Muscarinic Antagonists |
Suppliers and Packaging for NDA: 211362
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE | atropine sulfate; diphenoxylate hydrochloride | TABLET;ORAL | 211362 | ANDA | Winder Laboratories LLC | 75826-107 | 75826-107-00 | 1000 TABLET in 1 BOTTLE, PLASTIC (75826-107-00) |
DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE | atropine sulfate; diphenoxylate hydrochloride | TABLET;ORAL | 211362 | ANDA | Winder Laboratories LLC | 75826-107 | 75826-107-03 | 100 TABLET in 1 BOTTLE, PLASTIC (75826-107-03) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 0.025MG;2.5MG | ||||
Approval Date: | Jan 27, 2021 | TE: | AA | RLD: | No |
Complete Access Available with Subscription